NCT06086431View on ClinicalTrials.gov

Dexamethasone Vs. Dexmedetomidine for ESPB in Pain Management After Pediatric Idiopathic Scoliosis Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

October 17, 2023

Primary Completion Date

September 24, 2024

Study Completion Date

November 5, 2024

Conditions
Scoliosis IdiopathicScoliosis; Adolescence
Interventions
DRUG

0.9% sodium chloride

administration of 0.5ml/kg of 0,2% ropivacaine + 0.01ml/kg 0.9% sodium chloride for the erector spine plane block

DRUG

Dexamethasone

administration of 0.5ml/kg of 0.2% ropivacaine with 0.1mg/kg Dexamethasone for the erector spine plane block

DRUG

Dexmedetomidine

administration of 0.5ml/kg of 0.2% ropivacaine with 0.1ug/kg Dexmedetomidine for the erector spine plane block

Trial Locations (1)

61-545

Department of Spine Diseases and Pediatric Orthopedics, University of Medical Sciences, Poznań, Poland, Poznan

All Listed Sponsors
lead

Poznan University of Medical Sciences

OTHER

NCT06086431 - Dexamethasone Vs. Dexmedetomidine for ESPB in Pain Management After Pediatric Idiopathic Scoliosis Surgery | Biotech Hunter | Biotech Hunter